Epidemiology of Ovarian Cancer, Methods Mol Biol, vol.472, pp.413-437, 2009. ,
DOI : 10.1007/978-1-60327-492-0_20
Cancer Statistics, 2008, Cancer statistics, pp.71-96, 2008. ,
DOI : 10.3322/CA.2007.0010
Toward the development of a universal grading system for ovarian epithelial carcinoma, Cancer, vol.32, issue.5, pp.893-901, 1998. ,
DOI : 10.1002/(SICI)1097-0142(19980301)82:5<893::AID-CNCR14>3.0.CO;2-W
Ovarian Tumorigenesis, The American Journal of Pathology, vol.164, issue.5, pp.1511-1518, 2004. ,
DOI : 10.1016/S0002-9440(10)63708-X
Gene Expression Profiles of Serous, Endometrioid, and Clear Cell Subtypes of Ovarian and Endometrial Cancer, Clinical Cancer Research, vol.11, issue.18, pp.116422-6430, 2005. ,
DOI : 10.1158/1078-0432.CCR-05-0508
Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies, PLoS Medicine, vol.123, issue.12, p.232, 2008. ,
DOI : 10.1371/journal.pmed.0050232.st004
A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2, Nature Genetics, vol.447, issue.9, pp.41996-1000, 2009. ,
DOI : 10.1093/hmg/ddp078
Gene expression in ovarian cancer reflects both morphology and biological behavior, distinguishing clear cell from other poor-prognosis ovarian carcinomas, Cancer Res, issue.16, pp.624722-4729, 2002. ,
KLK6 and KLK13 predict tumor recurrence in epithelial ovarian carcinoma, British Journal of Cancer, vol.26, issue.7, pp.1107-1113, 2009. ,
DOI : 10.1158/1078-0432.CCR-07-1409
Role of Chemokine Network in the Development and Progression of Ovarian Cancer: A Potential Novel Pharmacological Target, Journal of Oncology, vol.71, issue.2, p.426956, 2010. ,
DOI : 10.1016/j.jnutbio.2006.08.006
Chemokines and chemokine receptors: new insights into cancer-related inflammation, Trends in Molecular Medicine, vol.16, issue.3, pp.133-144, 2010. ,
DOI : 10.1016/j.molmed.2010.01.003
The role of cytokines in the epithelial cancer microenvironment, Seminars in Cancer Biology, vol.12, issue.2, pp.113-120, 2002. ,
DOI : 10.1006/scbi.2001.0419
Stroma-derived factor (SDF-1/CXCL12) and human tumor pathogenesis, AJP: Cell Physiology, vol.292, issue.3, pp.987-95, 2007. ,
DOI : 10.1152/ajpcell.00406.2006
Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells, Nature Medicine, vol.7, issue.12, pp.1339-1346, 2001. ,
DOI : 10.1038/nm1201-1339
Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer, Cancer Res, issue.20, pp.625930-5938, 2002. ,
CXCL12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancers, Cancer Res, vol.65, issue.2, pp.465-472, 2005. ,
Epithelial cancer cell migration: a role for chemokine receptors?, Cancer Res, issue.13, pp.614961-4965, 2001. ,
Involvement of SDF-1??/CXCR4 axis in the enhanced peritoneal metastasis of epithelial ovarian carcinoma, International Journal of Cancer, vol.276, issue.1, pp.91-99, 2008. ,
DOI : 10.1002/ijc.23083
Microenvironmental Regulation of Chemokine (C-X-C-Motif) Receptor 4 in Ovarian Carcinoma, Molecular Cancer Research, vol.8, issue.5, pp.653-664, 2010. ,
DOI : 10.1158/1541-7786.MCR-09-0463
In ovarian cancer the prognostic influence of HER2/neu is not dependent on the CXCR4/SDF-1 signalling pathway, British Journal of Cancer, vol.5, issue.3, pp.96485-491, 2007. ,
DOI : 10.1006/gyno.1995.1099
Expression of chemokine CXCL12 and its receptor CXCR4 in human epithelial ovarian cancer: An independent prognostic factor for tumor progression, Gynecologic Oncology, vol.103, issue.1, pp.226-233, 2006. ,
DOI : 10.1016/j.ygyno.2006.02.036
Ovarian Surface Epithelium: Biology, Endocrinology, and Pathology, Endocrine Reviews, vol.22, issue.2, pp.255-288, 2001. ,
DOI : 10.1210/er.22.2.255
Ovarian Cancer Pathogenesis: A Model in Evolution, Journal of Oncology, vol.42, issue.8-9, p.932371, 2010. ,
DOI : 10.1038/nrc2618
HER-2 overexpression is an independent marker of poor prognosis of advanced primary ovarian carcinoma: a multicenter study of the GINECO group, Annals of Oncology, vol.15, issue.1, pp.104-112, 2004. ,
DOI : 10.1093/annonc/mdh021
HER2 Status in Ovarian Carcinomas: A Multicenter GINECO Study of 320 Patients, PLoS ONE, vol.144, issue.11, pp.2-1138, 2007. ,
DOI : 10.1371/journal.pone.0001138.t003
Phase III Trial of Carboplatin Plus Paclitaxel With or Without Gemcitabine in First-Line Treatment of Epithelial Ovarian Cancer, Journal of Clinical Oncology, vol.28, issue.27, pp.4162-4169, 2010. ,
DOI : 10.1200/JCO.2009.27.4696
Expression of candidate tumor markers in ovarian carcinoma and benign ovary: Evidence for a link between epithelial phenotype and neoplasia, Human Pathology, vol.35, issue.8, pp.1014-1021, 2004. ,
DOI : 10.1016/j.humpath.2004.04.014
Identification of glucocorticoid-induced leucine zipper as a key regulator of tumor cell proliferation in epithelial ovarian cancer, Molecular Cancer, vol.8, issue.1, p.83, 2009. ,
DOI : 10.1186/1476-4598-8-83
URL : https://hal.archives-ouvertes.fr/inserm-00663931
11:97 http://www.biomedcentral.com/1471-2407/11/97 expression of SDF-1 by mesothelial cells and biliary ductal plate epithelial cells, BMC Cancer Proc Natl Acad Sci, issue.15, pp.968585-8590, 1999. ,
Role of the Chemokine Stromal Cell-Derived Factor 1 in Autoantibody Production and Nephritis in Murine Lupus, The Journal of Immunology, vol.170, issue.6, pp.3392-3400, 2003. ,
DOI : 10.4049/jimmunol.170.6.3392
URL : https://hal.archives-ouvertes.fr/pasteur-00166866
The Chemokine SDF-1/CXCL12 Contributes to T Lymphocyte Recruitment in Human Pre-ovulatory Follicles and Coordinates with Lymphocytes to Increase Granulosa Cell Survival and Embryo Quality, American Journal of Reproductive Immunology, vol.202, issue.5, pp.270-283, 2005. ,
DOI : 10.1095/biolreprod.102.012211
Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 Secretion, Cell, vol.121, issue.3, pp.335-348, 2005. ,
DOI : 10.1016/j.cell.2005.02.034
Primary ex vivo cultures of human fallopian tube epithelium as a model for serous ovarian carcinogenesis, Oncogene, vol.60, issue.8, pp.291103-1113, 2010. ,
DOI : 10.1038/nature07955
Ovarian Cancer Metastasis: Integrating insights from disparate model organisms, Nature Reviews Cancer, vol.128, issue.5, pp.355-366, 2005. ,
DOI : 10.1016/j.devcel.2004.05.020
Silencing of epithelial CXCL12 expression by DNA hypermethylation promotes colonic carcinoma metastasis, Oncogene, vol.393, issue.36, pp.254986-4997, 2006. ,
DOI : 10.1038/sj.onc.1209505
Down-regulation of CXCL12 mRNA expression by promoter hypermethylation and its association with metastatic progression in human breast carcinomas, Journal of Cancer Research and Clinical Oncology, vol.119, issue.1, pp.91-102, 2009. ,
DOI : 10.1007/s00432-008-0435-x
Prognostic Significance of CXCL12 Expression in Patients With Colorectal Carcinoma, American Journal of Clinical Pathology, vol.132, issue.2, pp.202-210, 2009. ,
DOI : 10.1309/AJCPK35VZJEWCUTL
High levels of expression of human stromal cellderived factor-1 are associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinoma, Cancer Epidemiol Biomarkers Prev, issue.10, pp.192598-2604, 2010. ,
The Influence of Tumor-Host Interactions in the Stromal Cell-Derived Factor-1/CXCR4 Ligand/Receptor Axis in Determining Metastatic Risk in Breast Cancer, The American Journal of Pathology, vol.175, issue.1, pp.66-73, 2009. ,
DOI : 10.2353/ajpath.2009.080948
Expression of CXCL12 and its receptor CXCR4 in esophageal squamous cell carcinoma, Oncology Reports, vol.21, issue.1, pp.65-71, 2009. ,
DOI : 10.3892/or_00000190
The CXCR4/CXCL12 axis in endometrial cancer, Clinical & Experimental Metastasis, vol.62, issue.3, pp.261-268, 2009. ,
DOI : 10.1007/s10585-009-9240-4
Clinical and biological significance of CXCL12 and CXCR4 expression in adult testes and germ cell tumours of adults and adolescents, The Journal of Pathology, vol.14, issue.1, pp.94-102, 2009. ,
DOI : 10.1002/path.2436
Stromal cell-derived factor 1 alpha stimulates human glioblastoma cell growth through the activation of both extracellular signal-regulated kinases 1/2 and Akt, Cancer Res, issue.8, pp.631969-1974, 2003. ,
Tumor associated mesenchymal stem cells protects ovarian cancer cells from hyperthermia through CXCL12, International Journal of Cancer, vol.2010, issue.3, pp.715-725, 2010. ,
DOI : 10.1002/ijc.25619
Relationships between glycosaminoglycan and receptor binding sites in chemokines???the CXCL12 example, Carbohydrate Research, vol.343, issue.12, pp.2018-2023, 2008. ,
DOI : 10.1016/j.carres.2008.01.047
URL : https://hal.archives-ouvertes.fr/hal-00274461
The Chemokine SDF-1/CXCL12 Binds to and Signals through the Orphan Receptor RDC1 in T Lymphocytes, Journal of Biological Chemistry, vol.280, issue.42, pp.28035760-35766, 2005. ,
DOI : 10.1074/jbc.M508234200
CXCR7, CXCR4 and CXCL12: An eccentric trio?, Journal of Neuroimmunology, vol.198, issue.1-2, pp.9-13, 2008. ,
DOI : 10.1016/j.jneuroim.2008.04.020
A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development, The Journal of Experimental Medicine, vol.62, issue.9, pp.2201-2213, 2006. ,
DOI : 10.1084/jem.188.10.1917
CXCL12/SDF1 expression by breast cancers is an independent prognostic marker of disease-free and overall survival, European Journal of Cancer, vol.45, issue.14, pp.452579-2587, 2009. ,
DOI : 10.1016/j.ejca.2009.06.026